Cairo – Mubasher: Glaxo SmithKline – Egypt launched a new production line worth EGP 60 million, said Minister of Investment Dalia Khorshid.
The new production line capacity is up to 30 million units annually and comes in the framework of the company’s four – years scheduled expansion plan.
Glaxo SmithKline investments in Egypt stand at nearly $800 million, noted Khorshid.
Earlier, GlaxoSmithKline said it intends to pump investments reaching EGP 400m into Egypt until 2017.
